image
image
user-login
arrow
RUFENAC NEC ETHICS PHARMACEUTICALS (P) LTD
R

RUFENAC
NEC ETHICS PHARMACEUTICALS (P) LTD

RUFENAC is a Trademark filed on Mar 22, 1991 in through IP Office.The Trademark is registered to NEC ETHICS PHARMACEUTICALS (P) LTD and was filed by attorney.

R

RUFENAC NEC ETHICS PHARMACEUTICALS (P) LTD Trademark Information

Application ID

547676

Status

Abandoned

Date of Application

Mar 22, 1991

Classes

5

Proprietor(s)

NEC ETHICS PHARMACEUTICALS (P) LTD

Related trademark

RUFENAC AMINA LIMITED

Formalities Chk Pass

Class -5
RUFENAC SHALINA LABORATORIES PVT. LTD

Opposed

Class -5

FAQs

The application for RUFENAC was made on Mar 22, 1991
The trademark applicant for RUFENAC is NEC ETHICS PHARMACEUTICALS (P) LTD.
Trademark application has been filed under the class(es) 5.
As per IP India, trademark application is on the following stage: Abandoned.
Listed application Id of RUFENAC is 547676.
RUFENAC Trademark is a undefined mark.
Disclaimer: Vakilsearch assumes no responsibility or liability for any errors or omissions in the content of this page. The data is derived from mca.gov.in and ipindia.gov.in
bulb
Don’t lose your brand like ”
Our experts are here to assist you in finding a similar trademark.
  • No results found
1 Lakh+
TM Registered since 2011
trademark
star
4.5/5
(19k+ reviews)
google

footer-service

By continuing past this page, you agree to our Terms of Service Cookie Policy Privacy Policy  and  Refund Policy  © - Uber9 Business Process Services Private Limited. All rights reserved.

Uber9 Business Process Services Private Limited, CIN - U74900TN2014PTC098414, GSTIN - 33AABCU7650C1ZM, Registered Office Address - F-97, Newry Shreya Apartments Anna Nagar East, Chennai, Tamil Nadu 600102, India.

Please note that we are a facilitating platform enabling access to reliable professionals. We are not a law firm and do not provide legal services ourselves. The information on this website is for the purpose of knowledge only and should not be relied upon as legal advice or opinion.